Autosomal Dominant Retinitis Pigmentosa Due to Class B <i>Rhodopsin</i> Mutations: An Objective Outcome for Future Treatment Trials
Gene therapy for adRP due to <i>RHO</i> mutations was recently shown to prevent photoreceptor death in a canine model of Class B disease. Among translational steps to be taken, one is to determine a method to detect efficacy in a human clinical trial. The relatively slow progression of a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/21/5344 |